MedTrace Logo

For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol

NCT02870374 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2016-08-17

No results posted yet for this study

Summary

The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.

The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol

Conditions

  • Kidneys Transplantation

Interventions

BEHAVIORAL

Answering specific quality of life questionnaire in kidneys transplantation population

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Urielle DESALBRES · Assistance Publique Hôpitaux de Marseille

  • Stéphanie GENTILE, MD/PhD · Assistance Publique Hôpitaux de Marseille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-03-31
Completion
2017-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02870374 on ClinicalTrials.gov